Gipharma heads for CPhI Worldwide 2014 with new strengths


Gipharma heads for CPhI Worldwide 2014 with new strengths


GIPharma Logo

Press Release | Gipharma Srl

SEPTEMBER 22, 2014

Saluggia, Italy: –Injectables small volume liquids, lyophilized parenterals and radiopharmaceuticals specialist Gipharma has announced it will be present at forthcoming CPhI Worldwide 2014 exhibition, taking place at Paris Nord Villepinte.

The CMO will be represented in Paris by Commercial Director, Andrea Confetti, who will be available for face-to-face meetings and online partnering hook-ups throughout the first two days of the event.

“I am really looking forward to attending CPhI this year,” said Mr. Confetti.

“This is a wonderful event for meeting old friends and making new ones and I expect to have many very interesting conversations about potential new projects,” he added.

New capabilities

“Gipharma has a very impressive suite of capabilities to place on the table in any collaboration,” said Andrea Confetti.

“I think our clients will be very interested to hear of progress on our upgraded logistics. At our Saluggia site we are rapidly approaching completion of our new expanded warehouse for raw materials, primary packaging components and ancillary equipment, with environmental monitoring well underway. This will be the final link in enabling a smoother flow of materials to feed our two production lines,” Mr. Confetti added.

About Gipharma

Gipharma Srl is based in Saluggia, northwest Italy, where it operates as a pharmaceutical contract manufacturing organization (CMO) for small volume injectable liquids and freeze-dried powders (aseptic and terminally sterilized processes). The company typically handles small/medium-sized product batches ranging from 5.000 to 14.000 vials.

Gipharma specializes in oxygen-sensitive products such as radiopharmaceutical cold kits, for which it has a long-standing experience and supplies all leading imaging players in Europe. It also provides services for analytical assays and for sterility and endotoxin testing of drug products and can release drug product and investigational medicinal product(IMP) batches for Europe. Its expertise also extends out to support services in PET radiopharmaceutical manufacturing and testing.

Gipharma is fully owned by Advanced Accelerator Applications SA, an international specialist in Molecular Nuclear Medicine.

About CPhl Worldwide

CPhI Worldwide bills itself as ‘the number one Pharma sourcing event’, offering delegates opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends.

The 2014 event is being held 7-9 October 2014 at the Paris Nord Villepinte exhibition center and is expected to be the biggest CPhI Worldwide event to date, attracting more than 35,000 delegates from some 140 countries along with around 2,500 exhibitors.

The CPhl show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.

The Pre-Connect Conference on October 6 comprises eight modules on current industry ‘hot topics’ from API sourcing to Trends in Oncology and offers specifically themed networking opportunities.

CPhl is staged by leading global B2B events organizer and publisher, UBM Live.

More information at http://www.cphi.com/europe/home

Media Contacts

Dr. Andrea Confetti, Commercial Director, Gipharma Srl, Italy
Tel: +39 0161 487 141
Email: a.confetti@gipharma.com

Resources

Click on Gipharma heads for CPhI with new strengths for more information.
Click on Gipharma to contact the company directly.


Supplier Information
Supplier: Gipharma Srl
Address: Strada Crescentino, 13040 Saluggia (Vc), Italy
Tel: +39 0161 487 141
Fax: +39 0161 487 140
Website: www.gipharma.com


Comments are closed.